Home 
Acta Virologica 2019 Acta Virologica Vol.63, No.3, p.309-315, 2019
Acta Virologica 2019 Acta Virologica Vol.63, No.3, p.309-315, 2019
Journal info
|
||
Select Journal
Journals
Bratislava Medical Journal Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Current articles 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Acta Virologica Vol.63, No.3, p.309-315, 2019 |
||
| Title: Growth activation of influenza virus by trypsin and effect of T-705 (favipiravir) on trypsin-optimized growth condition | ||
| Author: T. DAIKOKU, T. OKUDA, M. KAWAI, N. MORITA, T. TANAKA, M. TAKEMOTO, Y. FUKUDA, K. TAKAHASHI, N. NOMURA, K. SHIRAKI | ||
| Abstract: Influenza virus is activated by proteolytic cleavage of hemagglutinin by trypsin. After determining the optimal trypsin concentration, intracellular and extracellular influenza A/PR/8/34 (H1N1) and A/Victoria/361/2011 (H3N2) virus productions were compared in cultures treated with T-705 (favipiravir) and GS 4071 (an active form of oseltamivir). Although both drugs efficiently inhibited extracellular viral RNA release in a dose-dependent manner, T-705 inhibited it to the level of the inoculum without trypsin treatment, while GS 4071 inhibited it to a final level 10 times higher than that without trypsin. T-705 inhibited intracellular viral RNA production to the level of input virus in both trypsin-treated and untreated cells. In contrast, GS 4071 dose-dependently inhibited intracellular viral RNA production in cells treated with trypsin but allowed viral RNA synthesis. The level of maximum inhibition by GS 4071was 10 times higher than that of cells without trypsin and 1,000 times greater than the inoculum titer in cells without trypsin. T-705 inhibited both intracellular and extracellular virus production 1,000 and 10 times more strongly, respectively, than GS 4071. T-705 has powerful anti-influenza activity in the absence of trypsin and even in the trypsin-optimized growth condition, suggesting the therapeutic advantage in treatment of influenza complicated with bacterial pneumonia. |
||
| Keywords: influenza; T-705; Tamiflu; trypsin; bacterial trypsin-like protease | ||
| Published online: 09-Sep-2019 | ||
| Year: 2019, Volume: 63, Issue: 3 | Page From: 309, Page To: 315 | |
| doi:10.4149/av_2019_311 |
||
|
|
 download file |
|